In the BioHarmony Drug Report Database

"Preview" Icon

Avobenzone

Anthelios Sx, Capital Soleil (avobenzone) is a small molecule pharmaceutical. Avobenzone was first approved as Anthelios Sx on 2006-07-21. It is used to treat photosensitivity disorders in the USA.

 

Trade Name

 

Anthelios Sx, Capital Soleil
 

Common Name

 

avobenzone
 

ChEMBL ID

 

CHEMBL1200522
 

Indication

 

photosensitivity disorders
 

Drug Class

 

Image (chem structure or protein)

Avobenzone structure rendering